Moreover, the need for RRT among patients with AKI was higher in the TCZ group; however, it failed to reach statistical significance (43.7% versus 31.9%; p = 0.09) ( Table 2 ).
← all excerpts
The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study.
1
0.0900
0.0900